Literature DB >> 7503682

Attachment and entry of infectious pancreatic necrosis virus (IPNV) into CHSE-214 cells.

J Kuznar1, M Soler, G Farias, J C Espinoza.   

Abstract

Infectious pancreatic necrosis virus (IPNV) attaches to CHSE-214 cells through two types of cell components: specific and non-specific ones. Competition experiments with inactivated IPNV showed that IPNV requires specific components to productively infect cells. Just a low amount of adsorbed IPNV enters the cell. After 20 minutes, part of the adsorbed IPNV was internalized into acid compartments. Also, the viruses adsorbed on the cell surface require similar periods of time to escape from the neutralization of antibodies.

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7503682     DOI： 10.1007/bf01384345

Source DB:  PubMed          Journal:  Arch Virol        ISSN： 0304-8608            Impact factor:   2.574


  10 in total

1.  Further analysis on the structural proteins of infectious pancreatic necrosis virus.

Authors:  A Estay; G Farias; M Soler; J Kuznar
Journal:  Virus Res       Date:  1990-01       Impact factor: 3.303

2.  Biophysical studies of infectious pancreatic necrosis virus.

Authors:  P Dobos; R Hallett; D T Kells; O Sorensen; D Rowe
Journal:  J Virol       Date:  1977-04       Impact factor: 5.103

3.  Effect of ammonium chloride on the multiplication of infectious pancreatic necrosis virus.

Authors:  G Farías; E Navarrete; J Kiss; J Kuznar
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

Review 4.  Review article initial stages in infection with animal viruses.

Authors:  N J Dimmock
Journal:  J Gen Virol       Date:  1982-03       Impact factor: 3.891

5.  Uncoating of influenza virus in endosomes.

Authors:  A Yoshimura; S Ohnishi
Journal:  J Virol       Date:  1984-08       Impact factor: 5.103

6.  Identity between infectious pancreatic necrosis virus VR-299 and a Chilean isolate.

Authors:  E Espinoza; G Farías; M Soler; J Kuznar
Journal:  Intervirology       Date:  1985       Impact factor: 1.763

7.  Virus-specific RNA synthesis in cells infected by infectious pancreatic necrosis virus.

Authors:  P Somogyi; P Dobos
Journal:  J Virol       Date:  1980-01       Impact factor: 5.103

8.  Infectious pancreatic necrosis virus internalization and endocytic organelles in CHSE-214 cells.

Authors:  E Couve; J Kiss; J Kuznar
Journal:  Cell Biol Int Rep       Date:  1992-09

9.  Purification of infectious pancreatic necrosis virus by anion exchange chromatography increases the specific infectivity.

Authors:  A Carlsson; J Kuznar; M Varga; E Everitt
Journal:  J Virol Methods       Date:  1994-04       Impact factor: 2.014

Review 10.  Virus entry into animal cells.

Authors:  M Marsh; A Helenius
Journal:  Adv Virus Res       Date:  1989       Impact factor: 9.937
  10 in total
  6 in total

1.  Molecular determinants of infectious pancreatic necrosis virus virulence and cell culture adaptation.

Authors:  Haichen Song; Nina Santi; Oystein Evensen; Vikram N Vakharia
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

Review 2.  Drug and bioactive molecule screening based on a bioelectrical impedance cell culture platform.

Authors:  Sakthivel Ramasamy; Devasier Bennet; Sanghyo Kim
Journal:  Int J Nanomedicine       Date:  2014-12-10

3.  Virion glycosylation governs integrity and infectivity of infectious pancreatic necrosis virus.

Authors:  H Fridholm; E Everitt
Journal:  J Fish Dis       Date:  2011-09       Impact factor: 2.767

Review 4.  The Infectious Pancreatic Necrosis Virus (IPNV) and its Virulence Determinants: What is Known and What Should be Known.

Authors:  Carlos P Dopazo
Journal:  Pathogens       Date:  2020-02-04

5.  The effect of fingolimod on regulatory T cells in a mouse model of brain ischaemia.

Authors:  Kyle Malone; Andrea C Diaz Diaz; Jennifer A Shearer; Anne C Moore; Christian Waeber
Journal:  J Neuroinflammation       Date:  2021-01-30       Impact factor: 8.322

6.  Evaluation of the Antiviral Activity against Infectious Pancreatic Necrosis Virus (IPNV) of a Copper (I) Homoleptic Complex with a Coumarin as Ligand.

Authors:  Daniela Gutiérrez; Almendra Benavides; Beatriz Valenzuela; Carolina Mascayano; Maialen Aldabaldetrecu; Angel Olguín; Juan Guerrero; Brenda Modak
Journal:  Molecules       Date:  2021-12-22       Impact factor: 4.411
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.